Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 3Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Renal Cell 3Carcinoma, Hepatocellular 3Thyroid Neoplasms 1Prostatic Neoplasms 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neoplasms 1Lung Neoplasms 1Kidney Neoplasms 1Colorectal Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

trametinib 2anlotinib 2Thyroxine 2Surgical Procedures, Operative 2sintilimab 1selpercatinib 1pralsetinib 1pembrolizumab 1lenvatinib 1larotrectinib 1dabrafenib 1cabozantinib 1Vindesine 1Triiodothyronine 1TP protocol 1Radiofrequency Ablation 1Paclitaxel 1Gemcitabine 1Doxorubicin 1Docetaxel 1Decision Support Techniques 1Cyclophosphamide 1Conversion to Open Surgery 1Cisplatin 1CP protocol 1Bariatric Surgery 1(177)Lu-DOTA-EB-TATE 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Thyroid Neoplasms × cabozantinib × Clear all
NCT07010393 2025-06-08

Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study

Fujian Medical University

Phase 4 Not yet recruiting
335 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡